A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2004
11/25/2004	US20040235811 For therapy of rhinitis and asthma, particularly by inhalation, and for treating inflammation, particularly by local or topical administration
11/25/2004	US20040235810 Novel glucocorticoid receptor ligands for the treatment of metabolic disorders
11/25/2004	US20040235809 Epoxy steroidal aldosterone antagonist and beta-adremergic antagonist combination therepy for treatment of congestive heart failure
11/25/2004	US20040235808 Administering compounds such as 17 beta -[4-(dimethylamino)-benzoyloxy]-androst-4-en-3-one for modulating a function mediated by the androgen receptor in a tissue selective manner
11/25/2004	US20040235807 Administering formulation for intranasal drug administration, wherein the formulation comprises: a topically administrable decongestant;a topically administrable corticosteroid: and carrier that is suitable for nasal drug administration
11/25/2004	US20040235806 administering toremifene, and its pharmaceutically acceptable salt, hydrate, N-oxide or mixtures, as selective estrogen receptor modulators, for prophylaxis of bone disorders; antiestrogens
11/25/2004	US20040235805 Administering betulinic acid or derivatives thereof for therapy or prophylaxis of anxiety
11/25/2004	US20040235804 Multiple dose aromatase inhibitor for treating infertility
11/25/2004	US20040235803 Dispersible formulation of an anti-inflammatory agent
11/25/2004	US20040235802 Combinations comprising cox-2-inhibitors and aspirin
11/25/2004	US20040235801 Therapy for stroke
11/25/2004	US20040235800 Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
11/25/2004	US20040235799 Use of a compound with a negatively charged domain of radicals for the treatment of restenosis
11/25/2004	US20040235798 Identifying a small organic molecule having a core structure, the small organic molecule having a cytotoxic antifungal activity; andpreparing a compound comprising the core structure of the identified cytotoxic antifungal agent
11/25/2004	US20040235797 Methods for identifying compounds useful for inhibiting farnesyl diphosphate synthase
11/25/2004	US20040235796 For therapy of proliferative disease
11/25/2004	US20040235795 Administration of an agent produced from phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof in combination with additive selected from a group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters, phospholipids
11/25/2004	US20040235794 Remedies for respiratory diseases comprising sphingosine-1-phosphate receptor controller
11/25/2004	US20040235792 For inhibiting urokinase in therapy of disease
11/25/2004	US20040235791 Scar reduction
11/25/2004	US20040235790 Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol
11/25/2004	US20040235789 Isomaltooligosaccharides from Leuconostoc as neutraceuticals
11/25/2004	US20040235788 For stimulating the growth of bifidogenic bacteria and/or other beneficial bacteria, for use as food additives, sweeteners, and bulking agents
11/25/2004	US20040235786 Highly purified antiendotoxin compound
11/25/2004	US20040235785 Potentiator of antitumoral agents in the treatment of cancer
11/25/2004	US20040235783 Pharmaceutical compositions for the treatment of tumor diseases
11/25/2004	US20040235782 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis
11/25/2004	US20040235781 Pharmaceutical composition of antiviral agents
11/25/2004	US20040235780 Pharmaceutical composition of antiviral agents
11/25/2004	US20040235779 Synergistic mixture of tipranavir and 3'-deoxy-3'-fluorothymidine, -cytosine, -adenosine, and/or guanosine type derivatives; human T-cell leukemia/lymphoma virus, lymphadenopathy associated virus; AIDS
11/25/2004	US20040235778 Methods for regulating hematopoiesis using CpG-oligonucleotides
11/25/2004	US20040235777 Enhancing immune response to cancer antigen comprising by administering a CpG (cytosine-phosphate diester-guanine) oligonucleotide; thrombopoiesis, anemia
11/25/2004	US20040235774 Immunostimulatory nucleic acids for the treatment of asthma and allergy
11/25/2004	US20040235770 Topically administered to treat cancer and infections
11/25/2004	US20040235764 Methods of inhibiting expression of a target gene in mammalian cells
11/25/2004	US20040235762 Host vs. graft disease, leukemia, lymphoma; autoimmune disorders; fungicides; antitumor and antiproliferative agents
11/25/2004	US20040235761 Novel virus proliferaton inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue
11/25/2004	US20040235759 Increasing acute or chronic injection-site toleration in mammals by administering single dose descladinose azalide derivative mixture
11/25/2004	US20040235758 Foods; skin, lipid, liver, and cardiovascular disorders; hormone dependent diseases, osteopenia, osteoporosis,and acute ovarian estrogen deficiency; biosynthesis by metabolism of isoflavone; drug delivery
11/25/2004	US20040235757 Anticarcinogenic and antimetastasis agents; leukemia or Hodgkin's disease.
11/25/2004	US20040235756 Skin-protective compositions effective against vesicants & percutaneous chemical agents
11/25/2004	US20040235755 Modulating glycolysis enzyme complex/M2-PK and/or by inhibiting transaminases and/or separating the binding of the mitochondrial malate dehydrogenase to p36 protein
11/25/2004	US20040235753 Oxytocin agonists
11/25/2004	US20040235752 3-fluoro-pyrrolidines as antidiabetic agents
11/25/2004	US20040235751 Reduction of zinc-induced neurotoxic injury by blockade of nitric oxide synthesis
11/25/2004	US20040235742 Water channel opener compositions and medicinal compositions for ophthalmic use
11/25/2004	US20040235739 Administering 5-isoquinolinesulfonamide derivative as an antiischemic or antihypoxic agent; tissue plasminogen activator or hedgehog therapeutic acts as protein kinase C inhibitor
11/25/2004	US20040235736 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
11/25/2004	US20040235728 Compositions and methods for treating osteoporosis
11/25/2004	US20040235727 Comprising H 376/95, sodium dodecyl sulphate, and a polymer selected from hydroxypropyl methylcellulose, hydroxyethyl cellulose, and polyoxyethylene oxide; use in treatment of thromboembolism
11/25/2004	US20040235723 Introducing ABC protein gene into yeast cell having high drug sensitivity to prepare transformed cell where protein is expressed in cell membrane, incubating cell in presence of test substance and substance which is subjected to active transfer outside cell by ABC protein in cell membrane, comparing
11/25/2004	US20040235720 May also be used in combination with an interferon for treatment and/or prevention of diseases such as traumatic nerve injury, stroke, demyelinating diseases of the CNS or PNS, neuropathies and neurodegenerative diseases
11/25/2004	US20040235718 Use of Afamin, in particular in combination with vitamin E, is for treatment of oxidative stress; treatment of Alzheimer's Disease, Huntington's Disease or amyotropic lateral sclerosis
11/25/2004	US20040235712 Coordination complexes having tethered therapeutic agents and/or targeting moieties, and methods of making and using the same
11/25/2004	US20040235175 Method for transfection of rna using electrical pulses
11/25/2004	US20040235171 Using post-transcriptional silencing to treat cell proliferative disorders associated with human papiloma viral infection; RNA interference; antitumor/antiviral agents
11/25/2004	US20040235164 Antisense nucleotide sequences for use in the prevention and treatment of asthmatic disorders; gene expression ihibition
11/25/2004	US20040235163 Comprises regulatory agent which prevents apoptosis and/or cardiac oxidative stress in myocardial tissues; identifying modulators of atp sensitive potassium channels
11/25/2004	US20040235106 18891, a novel human lipase
11/25/2004	US20040235097 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
11/25/2004	US20040235082 Fat regulation
11/25/2004	US20040235066 Using immunoglobulin specific to cancer testis-antigens for use in diagnosis and treatment of cell proliferative diseaes; immunotherapy
11/25/2004	US20040235044 Chain-shortened polynucleotide and method for preparation thereof
11/25/2004	US20040235018 Nucleotide sequences coding zinc finger protein for use in identifying modulators of cell proliferation disorders; antitumor agents
11/25/2004	US20040235006 Chemical compounds
11/25/2004	US20040234999 Biopolymer mixtures for use in the inhibition of gene expression; RNA interference and gene therapy
11/25/2004	US20040234993 Comprises nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of asthma, chronic obstructive pulmonary disease (COPD) and arthritis
11/25/2004	US20040234969 Using cytochrome p450 gene expression as diagnostic indicator of steroid responsiveness; identifying modulators for treatment and prevention of skin and allergic disorders
11/25/2004	US20040234960 Evaluating methylation status of nucleotide sequences; treat sequences and convert cytosine to uracil, amplify segment comprising 5-methyl cytosine, hybridize with peptide nucleic acid and oligomers, evaluate methylation and quantify amplification products
11/25/2004	US20040234674 Artichoke leaf extracts
11/25/2004	US20040234634 Pharmaceutical compositions having appetite suppressant activity
11/25/2004	US20040234631 Composition comprising soy and use thereof in the provention and/or treatment of various diseases
11/25/2004	US20040234626 Food supplement for increasing lean mass and strength
11/25/2004	US20040234625 Pharmaceutical preparation useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
11/25/2004	US20040234624 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
11/25/2004	US20040234623 Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
11/25/2004	US20040234622 Sulfonamide derivatives
11/25/2004	US20040234621 Mixture of catalytic metal compound, coenzyme, reducing agents or oxidizer and adjuvant; applying as aerosol, or film to medical equipment, filters, air conditioner
11/25/2004	US20040234619 Administering low dosage of anti-pressor agent; sexual disorders
11/25/2004	US20040234617 Water extraction; centrifuging; separation; cooling; freeze drying; hypotensive agents
11/25/2004	US20040234614 Chitin microparticles and their medical uses
11/25/2004	US20040234611 Active material embedded into biocompatible polymer or lipid
11/25/2004	US20040234608 Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
11/25/2004	US20040234606 Localized vaginal delivery without detrimental blood levels
11/25/2004	US20040234601 Absorption in upper part oof digestive system; oral administering
11/25/2004	US20040234600 Sustained release dosage form: layer containing polyethylene glycol, polyvinylpyrrolidone and lubricant
11/25/2004	US20040234599 Composition and method for maintaining healthy mobile joints and cartilage
11/25/2004	US20040234596 Fast disintegrating meloxicam tablet
11/25/2004	US20040234594 Inhibiting gastric acid secretory; antiulcer agent; oral dosage form
11/25/2004	US20040234593 Diphenhydramine tannate compositions and methods of use
11/25/2004	US20040234592 Mixture containing thyroid hormone , ethanolamine and emulsifier
11/25/2004	US20040234589 Mixture with carrier; storage stability packaging; freeze drying
11/25/2004	US20040234585 multilayer lamination; reducing smoking
11/25/2004	US20040234584 Transdermal therapeutic system with fentanyl or related substances
11/25/2004	US20040234583 Transdermal therapeutic system (tts) with fentanyl as a active ingredient
11/25/2004	US20040234579 Self life; adjuvant mixed with carrier matrix; molding; freeze drying
11/25/2004	US20040234578 Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same
11/25/2004	US20040234575 Medical products comprising a haemocompatible coating, production and use thereof
11/25/2004	US20040234572 Preparation of sustained release pharmaceutical composition
11/25/2004	US20040234556 Aerosol mixture of drug particles in fluorohydrocarbon propellant

1 ... 4880 4881 4882 4883 4884 4885 4886 4887 4888 4889 4890 4891 4892 4893 4894 4895 4896 4897 4898 4899 4900 ... 7860